AI Enters Dentistry’s Third Dimension, Moving Beyond the Specialist’s Office

LOS ANGELES, CA – September 03, 2026 – The world of dental diagnostics, long divided between the routine 2D X-ray and the specialist’s complex 3D scan, is on the cusp of a major convergence. Dental AI firm Pearl today announced the commercial launch of Second Opinion 3D, its FDA-cleared artificial intelligence platform for Cone Beam Computed Tomography (CBCT) scans. The move makes cutting-edge 3D radiologic analysis, previously the domain of oral surgeons and radiologists, directly accessible to general dentists for the first time in the US and Canada, signaling a pivotal shift in how patient care is delivered and how foundational health issues are identified.

CBCT technology, which provides a detailed, volumetric view of a patient’s jaw, teeth, and surrounding structures, has been migrating from specialist clinics to general practices for years. However, the software tools and clinical workflows have lagged behind, leaving many general practitioners with powerful imaging hardware but without the means to efficiently interpret the vast amount of data it produces. Pearl’s launch directly targets this innovation gap, aiming to transform a complex diagnostic tool into an intuitive, chairside resource.

Bridging the Diagnostic Divide

At its core, the challenge for general dentists has been twofold: interpretation and integration. A single CBCT scan can contain hundreds of image slices, and a thorough review is a time-consuming task requiring a level of training most general dentists don’t possess. Furthermore, existing software was largely built for radiologists, not for a busy general practice trying to manage patient flow.

Second Opinion 3D tackles this by automating the most laborious part of the process. The AI automatically identifies and segments key anatomical structures—from the mandible and airway to individual teeth and the inferior alveolar nerve canal—and color-codes them in an interactive 3D model. This allows a dentist to quickly visualize the patient's anatomy, isolate specific areas of concern, and communicate findings more effectively.

“What I really wanted was something that would scan every slice, flag anything worth a second look, and take me straight to it,” said Dr. Todd Yerondopoulos of Enamel Creations in Pleasanton, CA. “That's exactly what it does. It's caught things I would've missed just focusing on the one area I came in to check. And when I'm sitting with a patient, I can isolate exactly what I'm looking at and show them, instead of trying to explain a blob on a screen. That changes how confident patients feel about the treatment plan we land on.”

Beyond the visual aid, Pearl has integrated two critical workflow features. Dentists can now request a formal report from a board-certified oral and maxillofacial radiologist directly within the software, eliminating the cumbersome process of exporting large files to a separate portal. Crucially, the system can also automatically convert 3D findings into the 2D images and documentation required by insurance payors, a manual task that previously burdened office staff and delayed claims.

“The value proposition is about making the technology you’ve already invested in more useful and efficient,” explained one industry analyst. “It’s not just about finding more pathologies; it’s about streamlining the entire diagnostic and administrative loop that follows a scan.”

Beyond the Tooth: A New Frontier in Systemic Health

The implications of democratizing CBCT analysis extend far beyond routine dental work. The technology offers a unique window into a patient’s broader health, a connection that medicine is increasingly recognizing. By making detailed 3D scans easier to interpret, AI could position the general dentist on the front lines of identifying markers for systemic disease.

“General dentists have invested in CBCT for years, but reading these scans well has traditionally required specialist-level training most practices don’t have,” noted Ophir Tanz, CEO and Founder of Pearl. “CBCT is one of the more exciting imaging modalities we have because of what it can reveal about a patient's health beyond their mouth. By making CBCT more accessible and useful for dentists, we’re advancing a technology that has a role to play in bridging the gap between dental medicine and systemic health.”

Pearl's platform is already laying the groundwork for this future. While its initial FDA clearance focuses on anatomical segmentation, the company has AI-powered pathology detection capabilities—including for identifying temporomandibular joint (TMJ) disorders, carotid artery calcifications (a risk factor for stroke), and sinus radiopacities—already available in Canada and pending regulatory approval in the U.S. and other markets. Empowering dentists to spot these incidental findings could fundamentally alter preventive care pathways, fostering earlier referrals and interdisciplinary collaboration between dental and medical professionals.

The AI Race Heats Up

Pearl's launch does not happen in a vacuum. The dental AI market is booming, with analysts projecting it to surpass $3 billion by the early 2030s. The company’s move into 3D diagnostics places it in direct competition with other well-funded players, most notably Overjet, which received its own FDA clearance for a CBCT analysis tool in late 2025.

However, Pearl holds a significant strategic advantage: it is currently the only company to have secured FDA 510(k) clearance for AI analysis of both 2D and 3D dental radiographs. This comprehensive regulatory footing, covering everything from standard bitewings to panoramic X-rays and full CBCT volumes, allows it to offer a unified platform that addresses the entire spectrum of a practice’s imaging needs. This integrated approach is further bolstered by a strategic investment from the American Dental Association (ADA) in late 2024, a powerful endorsement of the technology's potential.

By focusing Second Opinion 3D squarely on the workflow of the general dentist rather than the specialist, Pearl is making a calculated bet on where the bulk of the market is headed. As the technology becomes a standard of care, especially for multi-location practices and Dental Service Organizations (DSOs) seeking to standardize diagnostic quality across their networks, platforms that prioritize ease of use and seamless integration are likely to gain the most traction. This launch solidifies Pearl’s position not just as a technology pioneer, but as a key enabler of the next evolution in everyday dental care.